Lippo China Resources (00156) and Lippo (00226) jointly announced that on October 16, 2023, Healthway announced that they had received a letter from the SGX stating that the SGX has no objection to delisting, provided that the following conditions have been met: Healthway makes an immediate announcement on the proposed delisting; and Healthway submits written confirmation that it is unaware of any information that would have a significant impact on investors' decisions that Healthway has not yet published. Healthway announced that the above conditions have been met.
After receiving a letter of no objection from the SGX, Healthway will be delisted from the official listing list of the SGX after the delisting offer has been completed. The delisting offer will remain open until October 26, 2023 at 5:30 p.m. (Singapore time).